136 related articles for article (PubMed ID: 21489835)
21. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
22. Treatment of nonretroperitoneal residual germ cell tumor masses.
Katz MH; McKiernan JM
Urol Oncol; 2005; 23(6):431-9. PubMed ID: 16301123
[TBL] [Abstract][Full Text] [Related]
23. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
24. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
25. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
Williams SB; Steele GS; Richie JP
J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
[TBL] [Abstract][Full Text] [Related]
26. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
Stephenson AJ; Tal R; Sheinfeld J
J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
[TBL] [Abstract][Full Text] [Related]
27. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
Yoon GH; Stein JP; Skinner DG
Urol Oncol; 2005; 23(3):168-77. PubMed ID: 15907716
[TBL] [Abstract][Full Text] [Related]
28. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
Steyerberg EW; Keizer HJ; Messemer JE; Toner GC; Schraffordt Koops H; Fosså SD; Gerl A; Sleijfer DT; Donohue JP; Habbema JD
Cancer; 1997 Jan; 79(2):345-55. PubMed ID: 9010108
[TBL] [Abstract][Full Text] [Related]
29. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
30. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
Horvath LG; McCaughan BC; Stockle M; Boyer MJ
Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
[TBL] [Abstract][Full Text] [Related]
31. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
32. Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis.
Steyerberg EW; Marshall PB; Keizer HJ; Habbema JD
Cancer; 1999 Mar; 85(6):1331-41. PubMed ID: 10189139
[TBL] [Abstract][Full Text] [Related]
33. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Rick O; Bokemeyer C; Weinknecht S; Schirren J; Pottek T; Hartmann JT; Braun T; Rachud B; Weissbach L; Hartmann M; Siegert W; Beyer J
J Clin Oncol; 2004 Sep; 22(18):3713-9. PubMed ID: 15365067
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME
J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913
[TBL] [Abstract][Full Text] [Related]
35. Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
Deville JL; Gravis G; Salem N; Savoie PH; Esterni B; Walz J; Thomas P; Goncalves A; Viens P; Bladou F
Eur J Cancer Care (Engl); 2010 Nov; 19(6):827-32. PubMed ID: 19708949
[TBL] [Abstract][Full Text] [Related]
36. Surgical aspects in the treatment of patients with testicular cancer.
Richie JP
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
[TBL] [Abstract][Full Text] [Related]
37. Successful resection of massively enlarged residual pulmonary metastases from a nonseminomatous germ cell testicular tumor.
Nishida T; Nishiyama N; Inoue K; Kawata Y; Ichikawa T; Tsukioka T; Wakasa T; Wakasa K; Suehiro S
Osaka City Med J; 2006 Dec; 52(2):87-92. PubMed ID: 17330397
[TBL] [Abstract][Full Text] [Related]
38. [Retroperitoneal lymph node dissection for patients with advanced testicular tumor].
Takasaki N; Ueda H; Isurugi K
Hinyokika Kiyo; 1994 Oct; 40(10):957-61. PubMed ID: 7992714
[TBL] [Abstract][Full Text] [Related]
39. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
40. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party.
Stenning SP; Parkinson MC; Fisher C; Mead GM; Cook PA; Fossa SD; Horwich A; Jones WG; Newlands ES; Oliver RT; Stenwig AE; Wilkinson PM
Cancer; 1998 Oct; 83(7):1409-19. PubMed ID: 9762943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
